4BASEBIO PLC Logo

4BASEBIO PLC

Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.

4BB | IL

Overview

Corporate Details

ISIN(s):
GB00BMCLYF79
LEI:
213800E2DX9EAIUNCB30
Country:
United Kingdom
Address:
25 NORMAN WAY, CB24 5QE CAMBRIDGESHIRE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

4basebio PLC is a life sciences company specializing in the design, development, and GMP-compliant manufacturing of synthetic DNA for advanced therapy medicinal products (ATMPs). The company provides high-performance nucleic acid products, including its proprietary opDNA®, as a scalable and efficient alternative to traditional plasmid DNA. Its solutions are engineered to accelerate the development of next-generation therapeutics and vaccines, including gene therapies, cell therapies, and mRNA-based medicines. By supplying critical DNA templates, 4basebio enables pharmaceutical and biotechnology partners to streamline manufacturing workflows and advance their research and clinical programs more efficiently.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-10 12:30
Post-Annual General Meeting Information
4basebio Plc - Result of Extraordinary General Meeting
English 8.8 KB
2025-09-30 17:20
Director's Dealing
4basebio Plc - Director Dealing
English 33.3 KB
2025-09-29 08:00
Interim Report
4basebio Plc - Half-year Report
English 312.8 KB
2025-07-22 08:00
Share Issue/Capital Change
4basebio Plc - Employee Long Term Incentive Plan and Issue of Equity
English 11.8 KB
2025-07-08 11:30
Board/Management Information
4basebio Plc - Director Appointment, Board Change
English 18.6 KB
2025-07-03 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 41.5 KB
2025-07-03 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.6 KB
2025-07-02 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.6 KB
2025-07-02 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 41.5 KB
2025-06-27 19:05
Post-Annual General Meeting Information
4basebio Plc - Result of AGM
English 8.7 KB
2025-06-25 08:00
Share Issue/Capital Change
4basebio Plc - Exercise of Options
English 10.8 KB
2025-06-17 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.2 KB
2025-06-17 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.5 KB
2025-05-27 08:00
Report Publication Announcement
4basebio Plc - Final Results and Notice of AGM
English 296.1 KB
2025-03-25 11:15
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.4 KB

Automate Your Workflow. Get a real-time feed of all 4BASEBIO PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for 4BASEBIO PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cosma Spolka Akcyjna Logo
Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.
Poland COS
COSMO Pharmaceuticals N.V. Logo
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
Netherlands COPN
Crossject Logo
Develops needle-free auto-injectors for rapid drug delivery in medical emergencies.
France ALCJ
CTC BIO, INC. Logo
Develops pharmaceuticals and feed additives for human and animal health using fermentation tech.
South Korea 060590
Cuorips Inc. Logo
Develops iPS cell therapies, like a cardiomyocyte sheet for severe heart failure.
Japan 4894
curacle co., ltd. Logo
Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.
South Korea 365270
Curevac Logo
Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.
Germany CVAC
Curocell Inc. Logo
Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.
South Korea 372320
Cyfuse Biomedical K.K. Logo Japan 4892
Daebonglsco.,Ltd Logo
Develops raw materials and APIs for the personal care, pharmaceutical, and food industries.
South Korea 078140

Talk to a Data Expert

Have a question? We'll get back to you promptly.